신생아중환자 안전관리 강화를 위한 국내 약료서비스 현황 분석
Pharmaceutical Care Services in Korean Neonatal Intensive Care Units: A Multicenter Survey
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : Pharmaceutical care can reduce medication errors and improve patient safety in a neonatal intensive care unit (NICU). This study aimed to investigate pharmaceutical care services and roles of pharmacists for effective and safe medication use in Korean NICUs. Methods : This cross-sectional, electronic-based survey was conducted in December 2020. Questionnaires were sent to pharmacy directors of hospitals with NICUs in Korea. The questionnaire comprised items about hospital features, NICU-related pharmaceutical care, currently used computer programs for pharmaceutical services, and methods of communication with medical staff. Results : Thirty-three hospitals responded to the survey. The majority (78.8%) of these hospitals were tertiary hospitals, with 14 (42.4%) having an NICU pharmacist. Regarding workload, 21 hospitals had daily NICU work, with 17 pharmacists engaging in NICU work for 1–3 hours a day. Pharmacists in 66.7% of hospitals participated in ward rounds for clinical decision support and pharmacists in 31 hospitals performed consultations for pharmacotherapy or nutrition support. Providing information as requested by the medical staff and nutritional support monitoring were performed in all hospitals. Pharmacists performed the management of total parenteral nutrition orders in 84.9% of hospitals, patient medication chart review in 75.8% of hospitals, and correction of dosages by weight and age of neonates in 84.9% of hospitals. Identification and interventions for drug-related problems were conducted by pharmacists in 63.6% of hospitals. Pharmacists provided clinical pharmacokinetic services in 57.6% of hospitals. Most pharmacists stated that they communicated over the phone (81.8%), followed by advice forwarding software (57.6%) and in-person visits (54.5%). Computer software for nutrition support was used in all hospitals. Conclusion : Korean pharmacists provide a variety of pharmaceutical care services for effective and safe therapy of NICU patients. Further research is required to evaluate outcomes of pharmaceutical care in NICUs.
Abstract
Background : Pharmaceutical care can reduce medication errors and improve patient safety in a neonatal intensive care unit (NICU). This study aimed to investigate pharmaceutical care services and roles of pharmacists for effective and safe medication use in Korean NICUs. Methods : This cross-sectional, electronic-based survey was conducted in December 2020. Questionnaires were sent to pharmacy directors of hospitals with NICUs in Korea. The questionnaire comprised items about hospital features, NICU-related pharmaceutical care, currently used computer programs for pharmaceutical services, and methods of communication with medical staff. Results : Thirty-three hospitals responded to the survey. The majority (78.8%) of these hospitals were tertiary hospitals, with 14 (42.4%) having an NICU pharmacist. Regarding workload, 21 hospitals had daily NICU work, with 17 pharmacists engaging in NICU work for 1–3 hours a day. Pharmacists in 66.7% of hospitals participated in ward rounds for clinical decision support and pharmacists in 31 hospitals performed consultations for pharmacotherapy or nutrition support. Providing information as requested by the medical staff and nutritional support monitoring were performed in all hospitals. Pharmacists performed the management of total parenteral nutrition orders in 84.9% of hospitals, patient medication chart review in 75.8% of hospitals, and correction of dosages by weight and age of neonates in 84.9% of hospitals. Identification and interventions for drug-related problems were conducted by pharmacists in 63.6% of hospitals. Pharmacists provided clinical pharmacokinetic services in 57.6% of hospitals. Most pharmacists stated that they communicated over the phone (81.8%), followed by advice forwarding software (57.6%) and in-person visits (54.5%). Computer software for nutrition support was used in all hospitals. Conclusion : Korean pharmacists provide a variety of pharmaceutical care services for effective and safe therapy of NICU patients. Further research is required to evaluate outcomes of pharmaceutical care in NICUs.
참고문헌 (22)
- "Results of the 1st neonatal intensive care unit adequacy evaluation", SERVICE HIRA, ~ (2019)
- "Preterm birth"[URL]
- An SH, "Contributing factors on pharmacokinetic variability in critically ill neonates", Korean Journal of Clinical Pharmacy, 27(2), pp.63~68 (2017)
- Kunac DL, "Identification of priorities for medication safety in neonatal intensive care", Drug Safety, 28(3), pp.251~261 (2005)
- Jain S, "Medication errors in neonates admitted in intensive care unit and emergency department", Indian J Med Sci, 63(4), pp.145~151 (2009)
- Campino A, "Educational strategy to reduce medication errors in a neonatal intensive care unit", Acta Paediatr, 98(5), pp.782~785 (2009)
- Simpson JH, "Reducing medication errors in the neonatal intensive care unit", Arch Dis Child Fetal Neonatal Ed, 89(6), pp.F480~F482 (2004)
- Yang HR, "Clinical significance of the nutritional support team for preterm infants in a neonatal intensive care unit", Korean Journal of Pediatric Gastroenterology and Nutrition, 12(1), pp.39~45 (2009)
- Oh YK, "Neonatal total nutritional pharmacy service at intensive care unit at a university hospital in Korea", Korean Journal of Clinical Pharmacy, 23(2), pp.167~174 (2013)
- Kim YH, "Pharmacist Interventions in Neonatal Intensive Care Unit and Associated Cost Avoidance and Cost Savings", Journal of Korean Society of Health-System Pharmacists, 35(3), pp.281~291 (2018)
- An SH, "Pharmaceutical Care for Medication Safety in Critically Ill Neonates", Korean Journal of Clinical Pharmacy, 30(3), pp.143~148 (2020)
- Kaboli PJ, "Clinical pharmacists and inpatient medical care : a systematic review", Archives of internal medicine, 166(9), pp.955~964 (2006)
- Park TY, "The comparison analysis of the prevention of adverse drug events through order interventions by designated-pharmacists", Journal of Korean Society of Health-System Pharmacists, 31(1), pp.638~643 (2014)
- Krzyzaniak N, "A global perspective of the roles of the pharmacist in the NICU", Int J Pharm Pract, 25(2), pp.107~120 (2017)
- Service Standards for Hospitals Providing Neonatal Care, "British Association of Perinatal Medicine", British Association of Perinatal Medicine Neonatal Pharmacy London, ~ (2010)
- Mulholland PJ, "Pharmacists as nonmedical prescribers : what role can they play? The experience in a neonatal intensive care unit", European Journal of Hospital Pharmacy, 21(6), pp.335~338 (2014)
- Krzyżaniak N, "The role of the clinical pharmacist in the NICU : a cross-sectional survey of Australian and Polish pharmacy practice", Eur J Hosp Pharm, 25(e1), pp.e7~e16 (2018)
- De Jager Z, "What role does the clinical pharmacist play in the neonatal intensive care unit?", SA Pharmaceutical Journal, 81(7), pp.22~23 (2014)
- National Clinical Programme for Paediatrics &Neonatology: Model of Care for Neonatal Services in Ireland, "Murphy J", ~ (2015)
- Kim SL, "Impact of Clinical Decision Support System and Clinical Pharmacist in Pediatrics", Journal of Korean Society of Health-System Pharmacists, 24(3), pp.234~242 (2007)
- Anoop Rao, "Clinical decision support in the neonatal ICU", Semin Fetal Neonatal Med, 27(5), pp.101332~ (2022)
- Lukas Higi, "Description of a clinical decision support tool with integrated dose calculator for paediatrics", Eur J Pediatr, 181(2), pp.679~689 (2022)